Skip to main content

Advertisement

SpringerLink
Log in

Are Three Doses of Intravenous Tranexamic Acid more Effective than Single Dose in Reducing Blood Loss During Bilateral Total Knee Arthroplasty?

  • Original Article
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

Tranexamic acid (TXA) has shown to reduce perioperative blood loss after bilateral total knee arthroplasty (TKA). But dosage and schedule of administration are not clear in literature. This study was aimed to compare prospectively blood loss and transfusion requirement in bilateral TKA with 3-dose regimen versus a single intra-operative dose of intravenous TXA.

Methods

This prospective non-randomised controlled trial included 25 patients undergoing bilateral simultaneous TKA who received three doses of 1 g intravenous TXA (group 1). First dose was given prior to deflation of the tourniquet, followed by two more doses 6 h apart. The control group included 25 matched patients (group 2) receiving a single dose of 1 g intravenous TXA just prior to deflation of the tourniquet.

Results

Mean drop in haemoglobin was less in group 1 as compared to group 2, but this difference was not statistically significant (2.51 vs 2.93 g/dL, p = 0.210). Similarly mean drop in haematocrit was more in group 2 as compared to group 1, though it was not statistically significant (9.34 vs. 9.18, p = 0.868). The need for blood transfusions was more in group 2 compared to group 1, but this difference was not statistically significant (p = 0.601). Higher frequency of ecchymosis around the surgical site was noted in group 2 as compared to group 1, for which prophylactic low-molecular-weight heparin had to be stopped post-operatively, but this difference was not statistically significant (p = 0.065).

Conclusion

The study has failed to show any significant beneficial effect of three doses of TXA in TKA as compared to a single dose. Though a trend towards reduction in mean haemoglobin drop and decreased need for stopping LMWH in post-operative period was seen, the results were not statistically significant.

Level of Evidence

II, prospective non-randomised controlled trial

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wu, W. C., Smith, T. S., Henderson, W. G., Eaton, C. B., Poses, R. M., Uttley, G., et al. (2010). Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Annals of Surgery, 252(1), 11–17.

    Article  Google Scholar 

  2. Glance, L. G., Dick, A. W., Mukamel, D. B., Fleming, F. J., Zollo, R. A., Wissler, R., et al. (2011). Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology, 114(2), 283–292.

    Article  Google Scholar 

  3. Luo, Z. Y., Wang, H. Y., Wang, D., Zhou, K., Pei, F. X., & Zhou, Z. K. (2018). Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, Controlled Study. The Journal of arthroplasty, 33(3), 786–793. https://doi.org/10.1016/j.arth.2017.09.062.

    Article  Google Scholar 

  4. Wang, D., Wang, H. Y., Luo, Z. Y., Meng, W. K., Pei, F. X., Li, Q., et al. (2018). Blood-conserving efficacy of multiple doses of oral tranexamic acid associated with an enhanced-recovery programme in primary total knee arthroplasty: a randomized controlled trial. Bone Joint Journal, 100B(8), 1025–1032.

    Article  Google Scholar 

  5. Akgül, T., Büget, M., Salduz, A., Edipoğlu, İ. S., Ekinci, M., Küçükay, S., et al. (2016). Efficacy of preoperative administration of single high dose intravenous tranexamic acid in reducing blood loss in total knee arthroplasty: a prospective clinical study. Acta Orthopaedica et Traumatologica Turcica, 50(4), 429–431.

    Article  Google Scholar 

  6. George, D. A., Sarraf, K. M., & Nwaboku, H. (2015). Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty. European Journal of Orthopaedic Surgery and Traumatology, 25(1), 129–133.

    Article  CAS  Google Scholar 

  7. Hourlier, H., Reina, N., & Fennema, P. (2015). Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Archives of Orthopaedic and Trauma Surgery, 135(4), 465–471.

    Article  Google Scholar 

  8. Morrison, R. J. M., Tsang, B., Fishley, W., Harper, I., Joseph, J. C., & Reed, M. R. (2017). Dose optimisation of intravenous tranexamic acid for elective hip and knee arthroplasty: The effectiveness of a single pre-operative dose. Bone Joint Research, 6(8), 499–505.

    Article  CAS  Google Scholar 

  9. Li, Z. J., Zhao, M. W., & Zeng, L. (2018). Additional dose of intravenous tranexamic acid after primary total knee arthroplasty further reduces hidden blood loss. ChinMed Journal (Engl)., 131(6), 638–642.

    Google Scholar 

  10. Sehat, K. R., Evans, R. L., & Newman, J. H. (2004). Hidden blood loss following hip and knee arthroplasty: Correct management of blood loss should take hidden loss into account. Journal Bone Joint Surgery British, 86(4), 561–565.

    Article  CAS  Google Scholar 

  11. Blanié, A., Bellamy, L., Rhayem, Y., Flaujac, C., Samama, C. M., Fontenay, M., et al. (2013). Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study. Thrombosis Research, 131(1), e6–11. https://doi.org/10.1016/j.thromres.2012.11.006.

    Article  CAS  Google Scholar 

  12. Hill, J., Magill, P., Dorman, A., Hogg, R., Eggleton, A., Benson, G., et al. (2018). Assessment of the effect of addition of 24 hours of oral tranexamic acid post-operatively to a single intraoperative intravenous dose of tranexamic acid on calculated blood loss following primary hip and knee arthroplasty (TRAC-24): a study protocol for a randomised controlled trial. Trials, 19(1), 1–12.

    Article  Google Scholar 

  13. Mukherjee, S., Tripathy, S. K., Maiti, R., Nayak, C., Samal, B. P., Rao, B., et al. (2019). Single dose Intravenous Tranexamic acid may not be adequate to reduce blood loss and blood transfusion requirement in patients undergoing single stage bilateral total knee arthroplasty. Acta Orthopaedica Belgica, 85(3), 364–372.

    Google Scholar 

  14. Piolanti, N., del Chiaro, A., Matassi, F., Graceffa, A., Nistri, L., & Marcucci, M. (2018). Clinical and instrumental evaluation of two different regimens of tranexamic acid in total hip arthroplasty: a single-centre, prospective, randomized study with 80 patients. European Journal of Orthopaedic Surgery and Traumatology., 28(2), 233–237.

    Article  Google Scholar 

  15. Sun, Q., Yu, X., Wu, J. Z., Ge, W., Cai, M., & Li, S. (2017). Efficacy of a single dose and an additional dose of tranexamic acid in reduction of blood loss in total knee arthroplasty. Journal of Arthroplasty, 32(7), 2108–2112. https://doi.org/10.1016/j.arth.2016.10.003.

    Article  Google Scholar 

  16. Xie, J., Ma, J., Yao, H., Yue, C., & Pei, F. (2016). Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial. Journal of Arthroplasty, 31(11), 2458–2464. https://doi.org/10.1016/j.arth.2016.04.034.

    Article  Google Scholar 

  17. Iwai, T., Tsuji, S., Tomita, T., Sugamoto, K., Hideki, Y., & Hamada, M. (2013). Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. International Orthopaedics, 37(3), 441–445.

    Article  Google Scholar 

  18. Legnani, C., Oriani, G., Parente, F., & Ventura, A. (2019). Reducing transfusion requirements following total knee arthroplasty: Effectiveness of a double infusion of tranexamic acid. European Review of Medical Pharmacology Science, 23(5), 2253–2256.

    CAS  Google Scholar 

  19. Maniar, R. N., Kumar, G., Singhi, T., Nayak, R. M., & Maniar, P. R. (2012). Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients knee. Clinical Orthopaedics and Related Research, 470(9), 2605–2612.

    Article  Google Scholar 

  20. Alshryda, S., Sarda, P., Sukeik, M., Nargol, A., Blenkinsopp, J., & Mason, J. M. (2011). Tranexamicacid in total knee replacement: a systematic review and meta-analysis. Journal of Bone Joint Surg British., 93B(12), 1577–1585.

    Article  Google Scholar 

  21. Henry, D. A., Carless, P. A., Moxey, A. J., et al. (2011). Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2011(3), CD001886.

    Google Scholar 

  22. Sukeik, M., Alshryda, S., Haddad, F. S., & Mason, J. M. (2011). Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. Journal of Bone Joint Surgery British, 93(1), 39–46.

    Article  CAS  Google Scholar 

  23. Hardy, J. F., & Desroches, J. (1992). Natural and synthetic antifibrinolytics in cardiac surgery. Canadian Journal of Anaesthesia, 39(4), 353–365.

    Article  CAS  Google Scholar 

Download references

Funding

Nil.

Author information

Authors and Affiliations

  1. Department of Orthopaedics, All India Institute of Medical Sciences, Bathinda, Punjab, 151001, India

    Tarun Goyal

  2. Department of Orthopaedics, All India Institute of Medical Sciences, Rishikesh, India

    Arghya Kundu Choudhury & Tushar Gupta

Authors
  1. Tarun Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arghya Kundu Choudhury
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tushar Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tarun Goyal.

Ethics declarations

Conflict of interest

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical standard statement

The institutional ethics committee approved the study. Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article. The study was conducted in All India Institute of Medical Sciences, Rishikesh, India.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Research involving human participants and/or animals

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goyal, T., Choudhury, A.K. & Gupta, T. Are Three Doses of Intravenous Tranexamic Acid more Effective than Single Dose in Reducing Blood Loss During Bilateral Total Knee Arthroplasty?. JOIO 54, 805–810 (2020). https://doi.org/10.1007/s43465-020-00231-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43465-020-00231-2

Keywords

Search

Navigation